Research progress on occupational exposure and protection strategies of antineoplastic drugs

Abstract

Abstract: The antineoplastic drugsare one of the main treatment methods of tumor diseases,but occupational exposure will harm the occupational health of workers. The paper reviews the research on occupational hazards of antineoplastic drugs at home and abroad,analyzes its impact on the occupational safety of medical staff,and sums up targeted protective measures,so as to provide reference basis forthe construction of occupational safety systemfor medical staff,lay a solid foundation for reducing the occupational injury of people exposed to antineoplastic drugs and the healthy development of oncology specialty in the future,and provide reference for occupational disease prevention and control departments to formulate occupational environmental health standards and protective guidelines suitable for China's national conditions.

Key words: Antineoplastic drugs, Occupational safety, Exposure, Occupational hazard, Protection strategies

CLC Number:

CHENG Jintao, HUANG Xiaohong, ZHANG Shuangfei, YUAN Meng. Research progress on occupational exposure and protection strategies of antineoplastic drugs. [J]OCCUPATION AND HEALTH, 2023, 39(16): 2295-2299.

References

[1] 曹毛毛,陈万青.GLOBOCAN 2020全球癌症统计数据解读[J].中国医学前沿杂志(电子版),2021,13(3):63-69.
[2] SUNG H, FERLAY J,SIEGEL R L,et al.Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries[J].CA:a cancer journal for clinicians,2021,71(3):209-249.
[3] ASEFA S,AGA F,DINEGDE N G,et al.Knowledge and practices on the safe handling of cytotoxic drugs among oncology nurses working at tertiary teaching hospitals in Addis Ababa,Ethiopia[J].Drug Healthc Patient Saf.2021,13:71-80.
[4] SCARSELLI A,CORFIATI M,DI MARZIO D,et al.Evaluating antineoplastic agents and occupational exposures among Italian workers using SIREP surveillance system[J].J Occup Environ Med,2019,61(8):669-675.
[5] HON C Y,ABUITTA D.Causes of health care workers’ exposure to antineoplastic drugs:an exploratory study[J].Can J Hosp Pharm,2016,69(3):216.
[6] 李丹,周莹,王联君,等.2007—2019年北京市东城区居民恶性肿瘤死亡流行趋势分析[J].中国肿瘤,2021,30(12):911-918.
[7] LABECHE F,OUELLET C,ROBERGE B,et al.Occupational exposure to antineoplastic drugs: what about hospital sanitation personnel?[J].Int Arch Occup Environ Health,2021,94(8):1877-1888.
[8] 王凤,陈曾曾,闫永建.职业接触抗肿瘤药物对国内医务人员健康影响研究现状[J].中国职业医学,2016,43(5):615-617.
[9] 何海丽,吕菊红,鲁娟,等.抗肿瘤药物对医务人员健康影响及防护的研究现状和进展[J].解放军护理杂志,2004,21(2):33-34.
[10] 郝梦琳. 抗肿瘤药物注射剂暴露风险与分级管控研究[D].成都:电子科技大学,2020.
[11] 李云娥,郝志英,张文静,等.抗肿瘤药物职业暴露中尿液残留量测定方法的建立及应用[J].中国药物与临床,2018,18(3):323-325.
[12] 王泽娟,刘晓娜,陈刚,等.抗肿瘤药物的I期临床试验中保证静脉给药剂量精准的质控设计效果[J].中国临床药理学杂志,2016,32(24):2311-2314.
[13] 陈昌蕊,梅小红,黄小红.抗肿瘤药物暴露对医务人员的职业健康危害与防护[J].职业与健康,2021,37(19):2733-2736.
[14] FRANSMAN W,KAGER H,MEIJSTER T,et al.Leukemia from dermal exposure to cyclophosphamide among nurses in the Netherlands: quantitative assessment of the risk[J].Ann Occup Hyg,2014,58(3):271-282.
[15] 李伟,唐滟.抗肿瘤药物医嘱审核方法分析与探讨[J].现代医药卫生,2015,31(2):310-312.
[16] 郝梦琳,边原,周杨林,等.抗肿瘤药物职业暴露的研究进展[J].中国新药与临床杂志,2020,39(7):385-389.
[17] 黄小红,李洋,黄超,等.非肿瘤科护士抗癌危害性药品暴露风险及健康管理[J].中国医院管理,2019,39(7):63-65.
[18] 叶国萍.静脉药物配置中心对接触抗肿瘤药物护士健康的影响及自我防护要点分析[J].中外女性健康究,2016(7):226,219.
[19] 郝梦琳,边原,朱九群,等.四川省医务人员抗肿瘤药职业暴露调查分析[J].中国药房,2020,31(8):1009-1014.
[20] 程洪英,张玉玲.抗肿瘤药物对护士的职业危害及化学防护的研究[J].当代护士(上旬刊),2018,25(12):23-25.
[21] 薛乐刚,乔雪丽.2014—2015年淮安市第二人民医院抗肿瘤药物不良反应分析[J].现代药物与临床,2017,32(1):140-144.
[22] 盖垚,刘科华,彭小花.肿瘤相关科室护士化疗药物职业暴露现状及影响因素调查分析[J].实用临床医学,2018,19(2):95-97.
[23] 王晋予. 抗肿瘤药物不良反应分析[J].肿瘤基础与临床,2017,30(2):163-164.
[24] 申思,吕春梅,冯海燕,等.奥沙利铂神经毒性反应的防治及护理进展[J].实用临床医药杂志,2016,20(10):197-200.
[25] 朱蕙,左瑶,高志彬,等.职业接触抗癌药遗传毒性损伤的Meta分析[J].公共卫生与预防医学,2017,28(4):87-89.
[26] 金力奋,何继亮,张美辩.抗肿瘤药接触对护士的遗传损伤[J].环境与健康杂志,2003,20(1):21-22,49.
[27] HUANG X H,GAO C H,CAI W,et al.Effect of occupational exposure to antineoplastic drugs on DNA damage in nurses: a cross-sectional study[J].Occup Environ Med.2021,79(4):253-258.
[28] MUSAK L,SMERHOVSKY Z,HALASOVA E,et al.Chromosomal damage among medical staff occupationally exposed to volatile anesthetics,antineoplastic drugs,and formaldehyde[J].Scand J Work Environ Health,2013:618-630.
[29] CONNOR T H,LAWSON C C,POLOVICH M,et al.Reproductive health risks associated with occupational exposures to antineoplastic drugs in health care settings: a review of the evidence[J].J Occup Environ Med,2014,56(9):901-910.
[30] ROCHA S D,GOMES A N H,ZEN P R G,et al,Handling of antineoplastic drugs:a health concern among health care workers[J].Rev Bras Med Trab,2020,18(4):407.
[31] SPEARS N,LOPES F,STEFANSDOTTIR A,et al.Ovarian damage from chemotherapy and current approaches to its protection[J].Hum Reprod Update,2019,25(6):673-693.
[32] NASSAN F L,LAWSON C C,GASKINS A J,et al.Administration of antineoplastic drugs and fecundity in female nurses[J].Am J Ind Med,2019,62(8):672-679.
[33] 陈指龙,张晓春,薛立群,等.环磷酰胺致小鼠生精障碍作用研究[J].动物医学进展,2017,38(5):34-38.
[34] 沈国球,潘铁军,鲁功成,等.环磷酰胺对雄性大鼠生精功能的影响[J].中华实验外科杂志,2009(5):633-635.
[35] 李茂莲,张月英,王清馨,等.职业接触抗肿瘤药物对护士外周血T淋巴细胞亚群的影响[J].中华劳动卫生职业病杂志,2005,23(6):450-451.
[36] 胡志强,马雪,漆婷婷,等.新型冠状病毒肺炎疫情期间接受抗肿瘤治疗患者的药学监护[J].肿瘤预防与治疗,2020,33(2):100-105.
[37] 殷爽,刘丽.环境监测与生物监测在静脉药物配置中心抗肿瘤药物暴露评估中的应用研究[J].中国医学前沿杂志(电子版),2016,8(6):119-123.
[38] 刘隽怡,潘清波.浅析癌症现状以及抗癌药物的发展与前景[J].世界最新医学信息文摘,2019,19(26):103,105.
[39] 尹红梅. 某医院静脉用药调配中心工作人员抗肿瘤药物职业暴露评估研究[J].中国当代医药,2020,27(18):179-182.
[40] MUCCI N,DUGHERI S,FARIOLI A,et al.Occupational exposure to antineoplastic drugs in hospital environments: potential risk associated with contact with cyclophosphamide-and ifosfamide-contaminated surfaces[J].Med Pr,2020,24;71(5):519-529.
[41] 陈珺仪,向美焕,冯晓薇,等.静脉药物配置中心对接触抗肿瘤药物护士职业暴露的影响[J].岭南急诊医学杂志,2018,23(4):391-393.
[42] GURUSAMY K S,BEST L M J,TANGUAY C,et al.Closed‐system drug‐transfer devices plus safe handling of hazardous drugs versus safe handling alone for reducing exposure to infusional hazardous drugs in healthcare staff[J].Cochrane Database Syst Rev,2018,27;3(3):CD012860.
[43] 李芸,沈国荣,张晶晶,等.我国10家医院静脉药物调配中心抗肿瘤药物环境污染评估及工作人员防护措施效果比较[J].中国医院药学杂志,2021,41(24):2591-2596.
[44] 朱咪锡,张建中.用WEINAS自动配制系统调配抗肿瘤药物实践[J].药学服务与研究,2021,21(1):71-74.
[45] 李钧,李志宁.药品质量风险管理[M].北京:中国医药科技出版社,2011:2.
[46] 孙翠萍,严定强,杨军军.风险管理在预防PIVAS抗肿瘤药物职业危害中的应用[J].药学与临床研究,2017,25(3):271-274.
[47] 徐波,黎贵,张淑香.规范化疗职业防护保障护士自身安全[J].中国护理管理,2014,14(6):569-572.